Back to Search
Start Over
Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
- Source :
-
Gynecologic Oncology . May2021, Vol. 161 Issue 2, p342-346. 5p. - Publication Year :
- 2021
-
Abstract
- A 36-year-old transgender man (assigned female at birth) on exogenous testosterone therapy was found to have stage IIA ovarian endometrioid carcinoma, and underwent adjuvant chemotherapy. Diffuse androgen receptor expression in the tumor initiated a multidisciplinary discussion regarding the safety of continuing exogenous testosterone as gender-affirming hormone therapy. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 161
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 149967873
- Full Text :
- https://doi.org/10.1016/j.ygyno.2021.02.019